Watch Ticker

Revolution Medicines, Inc. Common Stock

Go to Revolution Medicines, Inc. Common Stock Website

$39.39

(%)
Live
Previous Close

$39.39

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$6.2 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR si...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time

Related tickers: RVMD.

Read Full Article

REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the first quarter 2024 on Wednesday, May 8, 2024, after market close. At 4:30 p.m. Eastern Time that day (1:30 p.m. Pacific Time), Revolution Medicines’ senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress.

Related tickers: RVMD.

Read Full Article
Trending Tickers
BTTX

XNAS

$0.01
(%)
OPRT

XNAS

$3.92
(%)
PALI

XNAS

$6.38
(%)
PRSO

XNAS

$1.39
(%)
ACRV

XNAS

$0.00
(%)